{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:09:54Z","timestamp":1793912994273,"version":"4.8.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.ijantimicag.2012.01.016","type":"journal-article","created":{"date-parts":[[2012,3,23]],"date-time":"2012-03-23T07:03:05Z","timestamp":1332486185000},"page":"407-413","source":"Crossref","is-referenced-by-count":123,"title":["Outpatient parenteral antimicrobial therapy (OPAT) in a teaching hospital-based practice: a retrospective cohort study describing experience and evolution over 10 years"],"prefix":"10.1016","volume":"39","author":[{"given":"D.A.","family":"Barr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Semple","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.A.","family":"Seaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2012.01.016_bib0005","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1542\/peds.54.3.358","article-title":"Outpatient intravenous medications in the management of cystic fibrosis","volume":"54","author":"Rucker","year":"1974","journal-title":"Pediatrics"},{"key":"10.1016\/j.ijantimicag.2012.01.016_bib0010","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/BF01690748","article-title":"Experience with a physician-directed, clinic-based program for outpatient parenteral antibiotic therapy in the USA","volume":"14","author":"Tice","year":"1995","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2012.01.016_bib0015","doi-asserted-by":"crossref","first-page":"451","DOI":"10.2165\/00019053-200018050-00004","article-title":"Cost analysis of an adult outpatient parenteral antibiotic therapy (OPAT) programme. A Canadian teaching hospital and Ministry of Health perspective","volume":"18","author":"Wai","year":"2000","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.ijantimicag.2012.01.016_bib0020","doi-asserted-by":"crossref","first-page":"440","DOI":"10.5694\/j.1326-5377.2002.tb04450.x","article-title":"5: Hospital-in-the-home treatment of infectious diseases","volume":"176","author":"Howden","year":"2002","journal-title":"Med J Aust"},{"key":"10.1016\/j.ijantimicag.2012.01.016_bib0025","first-page":"U1020","article-title":"Outpatient parenteral antimicrobial therapy (OPAT): a review of experience at Auckland Hospital","volume":"117","author":"Upton","year":"2004","journal-title":"N Z Med J"},{"key":"10.1016\/j.ijantimicag.2012.01.016_bib0030","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ijantimicag.2006.08.018","article-title":"Outpatient parenteral antibiotic therapy in Singapore","volume":"28","author":"Fisher","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2012.01.016_bib0035","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1179\/joc.2007.19.4.417","article-title":"Outpatient parenteral antibiotic therapy for bone and joint infections: an Italian multicenter study","volume":"19","author":"Esposito","year":"2007","journal-title":"J Chemother"},{"key":"10.1016\/j.ijantimicag.2012.01.016_bib0040","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/jac\/dkm210","article-title":"Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years","volume":"60","author":"Matthews","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2012.01.016_bib0045","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1093\/jac\/dkp343","article-title":"Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective","volume":"64","author":"Chapman","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2012.01.016_bib0050","first-page":"332","article-title":"Out-patient and home-parenteral antibiotic therapy (OHPAT): evaluation of the impact of one year's experience in Tayside","volume":"57","author":"Nathwani","year":"1999","journal-title":"Health Bull (Edinb)"},{"key":"10.1016\/j.ijantimicag.2012.01.016_bib0055","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1093\/jac\/dkp212","article-title":"Establishment of an outpatient and home parenteral antimicrobial therapy service at a London teaching hospital: a case series","volume":"64","author":"Hitchcock","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2012.01.016_bib0060","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1086\/420939","article-title":"Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines","volume":"38","author":"Tice","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2012.01.016_bib0065","doi-asserted-by":"crossref","first-page":"156","DOI":"10.5694\/j.1326-5377.1999.tb127711.x","article-title":"Hospital in the home: a randomised controlled trial","volume":"170","author":"Caplan","year":"1999","journal-title":"Med J Aust"},{"key":"10.1016\/j.ijantimicag.2012.01.016_bib0070","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/bmj.38309.447975.EB","article-title":"Randomised controlled trial of intravenous antibiotic treatment for cellulitis at home compared with hospital","volume":"330","author":"Corwin","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.ijantimicag.2012.01.016_bib0075","first-page":"CD007491","article-title":"Hospital at home admission avoidance","author":"Shepperd","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ijantimicag.2012.01.016_bib0080","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/jac\/dkp051","article-title":"Community-based outpatient parenteral antimicrobial therapy (CoPAT) for Staphylococcus aureus bacteraemia with or without infective endocarditis: analysis of the randomized trial comparing daptomycin with standard therapy","volume":"63","author":"Rehm","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2012.01.016_bib0085","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jinf.2003.10.001","article-title":"Evaluation of outpatient treatment with ertapenem in a double blind controlled clinical trial of complicated skin\/skin structure infections","volume":"48","author":"Gesser","year":"2004","journal-title":"J Infect"},{"key":"10.1016\/j.ijantimicag.2012.01.016_bib0090","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/jac\/dki092","article-title":"Nurse-led management of uncomplicated cellulitis in the community: evaluation of a protocol incorporating intravenous ceftriaxone","volume":"55","author":"Seaton","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2012.01.016_bib0095","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ijantimicag.2011.05.008","article-title":"Factors associated with outcome and duration of therapy in outpatient parenteral antibiotic therapy (OPAT) patients with skin and soft-tissue infections","volume":"38","author":"Seaton","year":"2011","journal-title":"Int J Antimicrob Agents"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2012.01.016_bib0100","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000048564","article-title":"The management of skin and soft tissue infections: outpatient parenteral antibiotic therapy in the United Kingdom","volume":"47","author":"Nathwani","year":"2001","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ijantimicag.2012.01.016_bib0105","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/jac\/dkq445","article-title":"Outpatient parenteral antibiotic therapy (OPAT) for bone and joint infections: experience from a UK teaching hospital-based service","volume":"66","author":"Mackintosh","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2012.01.016_bib0110","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ijantimicag.2008.01.006","article-title":"Experience with daptomycin in an infectious diseases service over 1 year: utility in an outpatient parenteral antibiotic programme","volume":"31","author":"Seaton","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2012.01.016_bib0115","first-page":"929","article-title":"Outpatient parenteral antimicrobial therapy: recent developments and future prospects","volume":"11","author":"Torok","year":"2010","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.ijantimicag.2012.01.016_bib0120","unstructured":"Health Protection Scotland. Quarterly report on the surveillance of Staphylococcus aureus bacteraemias in Scotland, April\u2013June 2011. Edinburgh, UK: Health Protection Scotland; 2011. Report No. 2011\/40."},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2012.01.016_bib0125","doi-asserted-by":"crossref","first-page":"i19","DOI":"10.1093\/jac\/dkp257","article-title":"Antimicrobial resistance in the UK and Ireland","volume":"64","author":"Reynolds","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2012.01.016_bib0130","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/jac\/dkp147","article-title":"Development of teicoplanin dosage guidelines for patients treated within an outpatient parenteral antibiotic therapy (OPAT) programme","volume":"64","author":"Lamont","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2012.01.016_bib0135","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1086\/515552","article-title":"Practice guidelines for community-based parenteral anti-infective therapy. ISDA Practice Guidelines Committee","volume":"25","author":"Williams","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2012.01.016_bib0140","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1469-0691.1998.tb00413.x","article-title":"Outpatient and home parenteral antibiotic therapy (OHPAT) in the UK: a consensus statement by a Working Party","volume":"4","author":"Nathwani","year":"1998","journal-title":"Clin Microbiol Infect"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485791200057X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092485791200057X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T12:25:30Z","timestamp":1641471930000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092485791200057X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S092485791200057X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2012.01.016","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}